Stay updated on Celecoxib Impact on SMN2 in SMA Clinical Trial
Sign up to get notified when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.

Latest updates to the Celecoxib Impact on SMN2 in SMA Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the study details.SummaryDifference18%

- Check55 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a new software release. This update does not change the visible content or how the page operates.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page shows a new revision tag v3.6.5 replacing the previous v3.6.4, indicating a small backend/content update to the page.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page shows a new revision tag 'Revision: v3.6.4' replacing 'Revision: v3.6.3', indicating a routine update to the page; this change does not appear to affect the study details or related content.SummaryDifference0.1%

Stay in the know with updates to Celecoxib Impact on SMN2 in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.